Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004;2004(1):CD003789.
doi: 10.1002/14651858.CD003789.pub2.

Paracetamol versus nonsteroidal anti-inflammatory drugs for rheumatoid arthritis

Affiliations

Paracetamol versus nonsteroidal anti-inflammatory drugs for rheumatoid arthritis

T Wienecke et al. Cochrane Database Syst Rev. 2004.

Abstract

Background: Nonsteroidal anti-inflammatory drugs (NSAIDs) are usually preferred for simple analgesics such as paracetamol for rheumatoid arthritis. It is not clear, however, whether the trade-offs between benefits and harms of NSAIDs are preferable to those of paracetamol (paracetamol is also called acetaminophen).

Objectives: To compare the benefits and harms of paracetamol with NSAIDs in patients with rheumatoid arthritis.

Search strategy: Medline Silverplatter, Embase databases were searched up until Sept 2002. Reference lists of identified articles were also searched.

Selection criteria: Randomised double-blind studies comparing paracetamol with an NSAID.

Data collection and analysis: Decisions on inclusion of trials and data extraction were performed by the two authors independently.

Main results: Four cross-over studies, published between 1968 and 1982, involving 121 patients, and four different NSAIDs were included. The generation of the allocation sequence and the use of methods to conceal the allocation were not described in any of the studies. The studies were double-blind but it was not clear whether the blinding was effective. Methods for collecting adverse effects were not described. The NSAIDs were preferred more often than paracetamol by the patients or the investigator. In the largest trial, 20 out of 54 patients (37%) preferred ibuprofen and 7 out of 54 (13%) paracetamol. Investigators preference (as established by joint tenderness, grip strength and joint circumference) was 17 out of 35 for diclofenac versus 5 out of 35 for paracetamol in another trial. However, because of the weaknessess in the trials, no firm conclusion can be drawn.

Reviewer's conclusions: When considering the trade off between the benefits and harms of non-steroidal anti-inflammatory drugs and paracetamol/acetaminophen, it is not known whether one is better than the other for rheumatoid arthritis. But people with rheumatoid arthritis and the researchers in the study did prefer non-steroidal anti-inflammatory drugs more than acetaminophen/paracetamol. There is a need for a large trial, with appropriate randomisation, double-blinding, test of the success of the blinding, and with explicit methods to measure and analyse pain and adverse effects.

PubMed Disclaimer

Conflict of interest statement

None known.

Update of

  • doi: 10.1002/14651858.CD003789

Similar articles

Cited by

References

References to studies included in this review

Munno 1982 {published data only}
    1. Munno O, Sarchi C. Effectiveness of tolmetin in rheumatoid arthritis: evaluation by means of a new method. Methods and Findings in Experimental and Clinical Pharmacology 1982;4(3):203‐6. - PubMed
Solomon 1974 {published data only}
    1. Solomon L, Abrams G. Voltaren in the treatment of rheumatoid arthritis. South African Medical Journal 1974;48(22):949‐52. - PubMed
Solomon 1977 {published data only}
    1. Solomon L, Abrams G. Bumadizone calcium in the treatment of rheumatoid arthritis. South African Medical Journal 1977;52(10):391‐3. - PubMed
Thompson 1968 {published data only}
    1. Thompson M, Fox H, Newell DH. Ibuprofen in the treatment of arthritis. Medical Proceedings 1968;14:579‐82.

References to studies excluded from this review

Brooks 1982 {published data only}
    1. Brooks PM, Dougan MA, Mugford S, Meffin E. Comparative effectiveness of 5 analgesics in patients with rheumatoid arthritis and osteoarthritis. Journal of Rheumatology 1982;9:723‐6. - PubMed
Hajnal 1959 {published data only}
    1. Hajnal J, Sharp J, Popert AJ. A method for testing analgesics in rheumatoid arthritis using a sequential Procedure. Annals of the Rheumatic Diseases 1959;18:189‐206. - PMC - PubMed
Hardin 1979 {published data only}
    1. Hardin JG, Kirk KA. Comparative effectiveness of five analgesics for the pain of rheumatoid synovitis. Journal of Rheumatology 1979;6(4):405‐12. - PubMed

Additional references

Arnett 1988
    1. Arnett FC, Edworthy SM, Block DA, et al. The 1987 revised American Rheumatoism Association criteria for classification of rheumatoid arthritis. Arthritis and Rheumatism 1988;31:315‐24. - PubMed
Bradley 1991
    1. Bradley JD, Brandt KD, Katz BP, Kalasinski LA, Ryan SI. Comparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee. New England Journal of Medicine 1991;325:87‐91. - PubMed
Chan 2004
    1. Chan A‐W, Hróbjartsson A, Haahr MT, Gøtzsche PC, Altman DG. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA 2004;291:2457‐65. - PubMed
Gibson 1985
    1. Gibson T, Clark B. Use of simple analgesics in rheumatoid arthritis. Annals of the Rheumatic Diseases 1985;44:27‐9. - PMC - PubMed
Gøtzsche 1990
    1. Gøtzsche PC. Sensitivity of effect variables in rheumatoid arthritis: A Meta‐analysis of 130 placebo controlled NSAID trials. Journal of Clinical Epidemiology 1990;43(12):1313‐8. - PubMed
Gøtzsche 2002
    1. Gøtzsche PC. Non‐steroidal anti‐inflammatory drugs. Clinical Evidence. London: BMJ Publications, 2002:1063‐70. - PubMed
Katzung 1998
    1. Katzung BG, editor. Basic and Clinical Pharmacolocy. 7th Edition. Stamford, Connecticut: Appleton and Lange, 1998.
Peto 1976
    1. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomised clinical trials requiring prolonged observation of each patient. I. Introduction and design. British Journal of Cancer 1976;34:585‐612. - PMC - PubMed
Pildal 2007
    1. Pildal J, Hróbjartsson A, Jørgensen KJ, Hilden J, Altman DG, Gøtzsche PC. Impact of allocation concealment on conclusions drawn from meta‐analyses of randomised trials. International Journal of Epidemiology 2007;36(4):847‐57. [DOI: 10.1093/ije/dym087] - DOI - PubMed
Ritchie 1968
    1. Ritchie DM, Boyle JA, McInnes JM, Jasani MK, Dalakos TG, Greieveson P, Buchanan WW. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Quarterly Journal of Medicine 1968;37(147):393‐406. - PubMed
Ropes 1958
    1. Ropes MW, Bennet GA, Cobb S, Jacox R, Jessar RA. 1958 Revision of diagnostic criteria for rheumatoid arthritis. Bulletin of the Rheumatic Diseases 1958;9(4):175‐176. - PubMed
Schulz 1995a
    1. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical Evidens of bias: Dimensions of Methodological Quality Associated With Estimates of Treatment Effects in Controlled Trials. JAMA 1995;273:408‐12. - PubMed
Schulz 1995b
    1. Schulz KF. Subverting Randomization in Controlled Trials. JAMA 1995;273:408‐12. - PubMed
Wolfe 1968
    1. Wolfe AM. The epidemiology of rheumatoid arthritis: A review. Bulletin of the Rheumatic Diseases 1968;19:518‐26. - PubMed
Woo 2005
    1. Woo WWK, Man S‐Y, Lam PKW, Rainer THR. Randomized Double‐Blind Trial Comparing Oral Paracetamol and Oral Nonsteroidal Antiinflammatory Drugs for Treating Pain After Musculoskeletal Injury. Annals of Emergency Medicine 2005;46:352‐361. - PubMed

References to other published versions of this review

Wienecke 2004
    1. Wienecke T, Gøtzsche PC. Paracetamol versus nonsteroidal anti‐inflammatory drugs for rheumatoid arthritis. Cochrane Database of Systematic Reviews 2004, Issue 1. [DOI: 10.1002/14651858.CD003789.pub2] - DOI - PMC - PubMed

Publication types

MeSH terms

Substances